Treatment of malignant gliomas with tgf-beta inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/517 (2006.01) A61K 31/505 (2006.01) A61K 31/53 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2551524

The invention concerns methods of treating malignant gliomas, by administering inhibitors of TGF-.beta. the TGF-.beta. signaling pathway, including molecules preferably binding to the type I TGF-.beta. receptor (TGF.beta.-R1). Preferably, the inhibitors are non-peptide small molecules, including quinazoline derivatives. The invention also concerns methods for reversing the TGF-.beta.-mediated effect on glioma cells to make them less refractile to signaling and other immune cells, comprising contacting a glioma cell or tissue in vivo or in vitro, with an inhibitor of TGF-.beta..

L'invention concerne des procédés de traitement de gliomes malins, par administration d'inhibiteurs de TGF-.beta. de la voie de signalisation de TGF-.beta., y compris des molécules se liant de préférence au récepteur de TGF-.beta. type I (TGF.beta.-R1). De préférence, les inhibiteurs sont de petites molécules non peptidiques, y compris des dérivés de quinazoline. L'invention concerne également des procédés pour inverser l'effet médié par TGF-.beta. sur les cellules du gliome afin de les rendre moins réfractiles aux cellules de signalisation et autres cellules immunitaires, qui consistent à mettre en contact une cellule ou un tissu du gliome, in vivo ou in vitro, avec un inhibiteur de TGF-.beta..

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of malignant gliomas with tgf-beta inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of malignant gliomas with tgf-beta inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of malignant gliomas with tgf-beta inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1388652

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.